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The connection between environmental public health regulations, 
regulatory science, and public health gains can, at times, be difficult to 
elucidate. Why? Some challenges are raised by the complex mosaic of 
federal and state regulatory decisions, differences in the implementa­
tion of those decisions at more local levels, the multiple determinants 
of disease, and temporal lags between exposure and ultimate health 
outcomes (National Research Council 2007). This difficulty in making 
linkages between regulations and health outcomes often necessitates 
the choice of indirect measurements of success such as process indica­
tors (e.g., number of facilities inspected) or emissions indicators (e.g., 
tonnage of pollutants captured). Such indirect indicators fail to make 
the necessary connection to human exposure or health outcomes. The 
challenge remains to make these linkages at the appropriate spatial and 
temporal scales to bolster the evidence base for environmental decision­
making [U.S. Environmental Protection Agency (EPA) 2008b].
Despite these difficulties, it remains incumbent on the environmen­
tal regulatory community to, where possible, “close the loop” by demon­
strating that regulations have achieved their intent. Developing ways to 
better understand the impact of regulations and policies is essential, and 
in the long run will help regulators to predict the public health impacts 
of incremental or major changes in regulatory actions that affect envi­
ronmental exposures (U.S. EPA 2007). This is a critical step in ensuring 
that the actions taken and resources spent by governments, the regulated 
community, and others are protecting public health. Further, it helps to 
identify where continued improvements could be made.
One notable area where the linkage between regulation and health 
outcomes has been made is in lead abatement. Figure 1 provides a 
concise view of how actions promulgated to reduce lead exposure can 
be arrayed across a hierarchy of indicators, making the necessary con­
nections between rules, actions, and outcomes that are necessary to 
evaluate results and plan next steps. Gaps in this chain that still existed 
in the 1970s, such as the relationship between air lead and blood lead, 
presented considerable obstacles to the promulgation of the health­based 
regulation limiting lead content of gasoline 
(Bridbord and Hanson 2009). That these link­
ages can now be made is testament to both the 
magnitude and ubiquity of the problem of lead 
contamination, the broad engagement of the 
scientific community over decades of research, 
and excellent planning to evaluate the outcomes of lead mitigation (e.g., 
Galke et al. 2005). Bridbord and Hanson’s (2009) narrative makes the 
important point that taking the lead out of gasoline has made possible 
further examination of the health effects of lower and lower levels of 
lead contamination, an example of where following up on the outcomes 
of regulatory activities has identified opportunities for further risk miti­
gation and public health promotion.
In the July 2009 issue of Environmental Health Perspectives, Gould 
(2009) used data accumulated over the past decade on the linkage 
between environmental lead exposures and health effects to present a 
compelling description of the potential costs and benefits of lead hazard 
control, concentrating on the residential lead paint hazard. In her analysis, 
Gould incorporated certain health, social, and behavioral costs and ben­
efits left out of earlier valuation analyses associated with lead (President’s 
Task Force 2000; U.S. EPA 2008a, 2008c) arguing, in effect, that these 
data have reached a level of maturity that permits their inclusion.
Gould had good reason for concentrating on lead paint for her 
analysis; 25% of the nation’s housing has significant hazards from 
lead­based paint in the form of deteriorated paint, dust lead, or bare 
soil lead (Jacobs et al. 2002). Abatement is a good indicator of success. 
The accumulated evidence is clear: Abatement reduces dust­lead load­
ings when measured as far out as 3 years after treatment (Dixon et al. 
2005). This abatement results in decreases in whole blood lead levels of 
approximately 20–26% within a year for population samples of chil­
dren with pre  abate  ment levels just above the current intervention level 
(geometric mean, 11 µg/dL; Galke et al. 2001) and at higher levels 
(23 µg/dL; Taha et al. 1999).
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Figure 1. The hierarchy of indicators described by the U.S. EPA (2007) and some examples of the indicators at these different levels related to environmental lead 
contamination. Abbreviations: HUD, U.S. Department of Housing and Urban Development; NAAQS, National Ambient Air Quality Standard; NHANES, National 
Health and Nutrition Examination Survey. Linkages made between these indicators can be used to evaluate the efficacy of current actions and to predict the 
potential impact of proposed actions. For a more detailed account of federal roles in lead paint abatement, see the President’s Task Force report (2000).
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Moreover, some analyses (e.g., Nriagu et al. 2006) suggest that 
the remaining problem of lead contamination is likely associated 
with the presence of peeling paint and cracked walls in housing 
rather than with variables associated with water use or potential air 
exposure. This applies even in an urban system with lead present in 
the water distribution system or with proximity to possible outdoor 
sources of lead contamina  tion such as factories, incinerators, repair 
shops, or gas stations.
Gould’s focus on paint hazard (Gould 2009) highlights the dra­
matic decrease in the level of lead exposure and associated biomarker 
levels due to the reduction of lead content in gasoline, household 
paint, industrial emissions, drinking water, food canning, and ceramic 
glazes. It also acknowledges, however, that a large problem remains. In 
Milwaukee, Wisconsin, for example, 15.7% of children living in neigh­
borhoods surrounding a former industrial corridor have blood lead 
levels ≥ 10 µg/dL [Agency for Toxic Substances and Disease Registry 
(ATSDR) 2008]. These children and others in lead exposure hot spots 
have not fully shared the bene  fits of the regulatory and mitigation 
actions that have brought the national average down to 1.5 µg/dL 
(U.S. EPA 2008b). The magnitude of this problem remains a public 
health challenge, and the associated lead exposure hazard is an obstacle 
to the revitalization of America’s cities and communities. 
U.S. EPA Administrator Lisa Jackson has commented on a 
number of occasions that science must be the determining factor in 
making decisions that affect the environmental health of America’s 
communities, that the determinations and process of our decisions 
must be transparent, and that eliminating disparities in the environ­
mental health of America’s communities must be paramount (Jackson 
2009a, 2009b, 2009c). The analysis by Gould (2009) offers an oppor­
tunity in all of these areas by bringing a broad consideration of pub­
licly available medical, economic, and social sciences to bear on the 
well­developed understanding of the sources and routes of lead expo­
sure. Further, Gould identifies and quantifies the costs and benefits 
of closing the book on a major remaining facet of our nation’s lead 
problem. In a real sense, she offers lead abatement as an example of a 
“green economy” for which modest investment can reap great returns. 
She also points to the importance, at this time, of considering the 
nation’s environmental health issues in a place­based context, show­
ing that while dramatic, initial environmental health gains have been 
made based on sector­based banning of lead from consumer products 
and through air and water regulation, the public health and economi­
cally critical increments that remain will need to be addressed through 
place­based targeting for a burden that disproportionately affects resi­
dents with lower socio  economic status.
Even with the inclusion of these additional factors, Gould’s esti­
mate (Gould 2009) might still be considered conservative because 
it concentrates almost wholly on children < 6 years of age. Recent 
research has identified associations between cumulative lead exposure 
and cognitive impairment, hypertension, and other health outcomes 
in older adults (Hu et al. 2007; Navas­Acien et al. 2007; Shih et al. 
2007). These adverse outcomes are worsened by coexposure to stress, 
including neighborhood psycho  social hazards (Glass et al. 2009; Peters 
et al 2007; cf. Gump et al. 2008). Although much of the research on 
older adults has focused on lead accumulated and stored in bone dur­
ing the lifetime, questions still remain about the role of concurrent 
exposure to lead from housing stock or other sources (Lin et al. 2004).
Most older Americans age in place, with 29% of adults 
> 65 years of age living in housing stock built in 1949 or ear­
lier. This is especially true for urban and rural communities in 
the Northeast and Midwest regions of the United States, where 
40–60% of older adults live in this housing stock (Golant 2008). 
Unfortunately, these are also the regions where lead­based paint 
hazards are most prevalent, particularly in this older housing; 57% 
of housing built in 1940–1959 and 81% built before 1940 con­
tain lead hazards (Jacobs et al. 2002), and risk of lead toxicity for 
children is highest in these regions, particularly in older housing 
stock (Bernard and McGeehin 2003). If the relationship between 
older housing stock and the percentage of older adults with ele­
vated blood lead remotely mirrors that in children (Bernard and 
McGeehin 2003; Sargent et al. 1997), then the problem of concur­
rent exposure may indeed be a serious one. 
In her analysis, Gould (2009) demonstrated significant benefits 
to improving public health by lead paint remediation or control, 
adding an economic basis to the health and exposure data that make 
a process indicator such as paint hazard abatement a reasonable sur­
rogate for exposure and health indicators for children. If the linkages 
found for children also apply to older adults, it will be important 
to assess whether additional, economically quantifiable benefit can 
be gained from remedia  tion aimed at aging adults, the most rapidly 
growing portion of the U.S. population.
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Guest Editorial
Adverse gene–environment interactions (G × E) probably influence 
most chronic diseases, including neurologic disorders and cancer. The 
genetic (G) contribution to different diseases varies, but several lines 
of evidence clearly show that non  genetic factors have high attribut­
able risks, often in the range of 80–90% (Willett 2002). The domi­
nance of non  genetic components highlights the importance of the 
environment (E) to chronic disease risks.
Genomic tools arising from the Human Genome Project (HGP), 
combined with bioinformatics studies, have allowed epidemiologists 
to examine the genetic component of chronic diseases. Genome­wide 
association studies offer glimpses of the roles that particular genes play 
in disease development. However, the genetic factors identified thus 
far have generally been of low penetrance (a few percent at most) and 
have mainly offered clues as to which G × E (and G × G) effects might 
be worth pursuing.
In contrast, the tools for quantitative assessment of exposures—
based on measurements of chemicals in air, water, food, and the 
human body—have changed little since the 1970s. The lack of 
high­throughput methods of exposure assessment has motivated 
epidemiolo  gists to rely upon self­reported data to categorize chemical 
exposures from envi­
ronmental, endog­
enous, and dietary 
sources. With the 
possible exceptions of 
smoking and alcohol 
consumption, such 
self­reports have been unreliable predictors of long­term exposure lev­
els and are poorly suited for detecting G × E effects. 
Although 30 years of investment in G now illuminates genetic 
determinants of diseases, we are still in the dark ages when it comes 
to quantifying E (i.e., human exposures). Recognizing the disparity in 
current knowledge between genes and environmental exposures, Wild 
(2005) defined the “exposome,” representing all environmental expo­
sures (including those from diet, lifestyle, and endogenous sources) 
from conception onward, as a quantity of critical interest to disease 
etiology. If we expect to have any success at identifying the effects of E, 
G, and G × E on chronic diseases, we must develop 21st­century tools 
to measure exposure levels in human populations. That is, we need an 
HGP­like commitment to quantify the exposome. 
Building Exposure Biology Centers to 
Put the E into “G × E” Interaction Studies
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